glp-1-based treatments approved for weight loss 2025 GLP-1 Pipeline Update: August - Prime Therapeutics Weight-loss drugs such as Ozempic

The study published in the Lancet took six years, Cipriani said, and included all the published and unpublished data that the scientists could find

These requirements include robust control of raw materials, manufacturing processes, aseptic practices, and finished-product testing to help ensure the quality and integrity of compounded sterile preparations

Available at: (Accessed on 16th December 2025)

Usage: For intravenous (i.v.) or infusion use only

V.KhudeP

For those who dont know, Ozempic is a drug that has become popular within the celebrity space for weight loss despite the fact that it has not been approved by the FDA for chronic weight management